BioHealth News Archive
How computer vision will redesign healthcare – MedCity News
Currently, we depend upon the eyes, ears, and touch of medical staff to examine the human body and diagnose patients. Physicians must identify abnormalities…
Read More
2017 Was A Banner Year For Innovation. But Will It Be Short-Lived?
2017 was an extraordinary year in the history of medicine. It was the year when scientists beat cancer, and U.S. regulators approved the first…
Read More
2017: A Banner Year for MdBio!
It’s hard to believe that the book has already closed on 2017. As we turn the calendar to 2018, I wanted to pause and…
Read More
BIOTECH AND MEDTECH SEED FUNDING: WHAT LIES AHEAD? – PANELLIST PREVIEW
The 4th annual Biotech and Money/Medtech and Money World Congress will offer insight into the investment landscape for biotech and medtech companies via a…
Read More
Alexandria Real Estate wants to plant a forest in life sciences building along I-5 in Seattle – Puget Sound Business Journal
Alexandria Real Estate recently completed a large building on the west side of Lake Union and now it's starting to plan one on Eastlake.…
Read More
AMA Incubator Invests $10 Million in Blockchain Health Startup – CoinDesk
Blockchain startup Akiri has received $10 million in Series A funding to develop a distributed ledger platform for health data. {iframe}https://www.coindesk.com/ama-incubator-invests-10-million-blockchain-health-startup/{/iframe}
Read More
Personal Genome Diagnostics closes $75 million financing round – Baltimore Sun
Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, has raised $75 million to expand access to genomic testing for cancer patients. {iframe}http://www.baltimoresun.com/business/bs-bz-pgdx-series-b-20180104-story.html{/iframe}
Read More
AUTM – FY2016 Licensing Survey
More than ever, academic technology transfer is driving economic development. The number of invention disclosures — a direct measure of institutional impact on innovation…
Read More
Boehringer Ingelheim expands Venture Funds to €250m – European Biotechnology
Originally, the BIVF was designed to put investments of up to €10-15m into early stage companies focused on immunomodulation, tissue regeneration, small and large molecule…
Read More
Bluefield Innovations thinks this JHU cancer research could become a new Baltimore company – Technical.ly Baltimore
Cancer research helmed by a Johns Hopkins radiation oncology professor is the first to receive backing from a fund backing work that might create…
Read More
Personal Genome Diagnostics closes $75M Series B, plans second Baltimore office – Technical.ly Baltimore
Canton-based Personal Genome Diagnostics closed on $75 million in Series B funding and plans to triple its square footage with a new office. {iframe}https://technical.ly/baltimore/2018/01/04/personal-genome-diagnostics-closes-75m-series-b-plans-second-baltimore-office/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=59788772&_hsenc=p2ANqtz-8lK_TzsmR3HEtnsa-fx7CpDfP887B5H_xhsLgNCyFZDQ-V2wvMkAMBgTHcijmaTeEr8lf65IgLdjDFo5H65jyuR4l0og&_hsmi=59788772{/iframe}
Read More
WellDoc Validates Potential of Its Digital Therapeutic, BlueStar®, to Significantly Reduce Healthcare Costs
WellDoc®, a leading digital health company, announced today that its clinically proven hemoglobin A1C reductions for users of its BlueStar® digital therapeutic with type…
Read More
‘Hey, Dude, Where’s My Exclusivity?’: United Therapeutics, FDA Tussle – Bloomberg BNA
Silver Spring, Md.-based United Therapeutics Corp. and the FDA are duking it out in court over whether the agency improperly denied the biotechnology company…
Read More
Emergent BioSolutions Initiates Phase 2 Clinical Study to Evaluate FLU-IGIV to Treat Serious Influenza A Infection
Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of a Phase 2 dose ranging study to evaluate the safety, pharmacokinetics, and clinical benefit of…
Read More
Xconomy: San Diego Life Sciences 2022: Photos and Takeaways
Making predictions can be a tricky business. Nevertheless, Xconomy recently brought together some of San Diego’s most prominent life sciences leaders to offer their…
Read More